Abstract
The reports on the impact of co-infection of hepatitis C virus (HCV) and human immunodeficiency virus (HIV) on the development of cardio-metabolic diseases have been conflicting. We evaluated the impact of HCV co-infection with incidence of diabetes, dyslipidemia, and major adverse cardiac events (
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
